Construct validation of the Health Utilities Index and the Child Health Questionnaire in children undergoing cancer chemotherapy

por Sung, L, Greenberg, M L, Doyle, J J, Young, N L, Ingber, S, Rubenstein, J, Wong, J, Samanta, T, McLimont, M, Feldman, B M
Publicado 2003

BRCA1 and BRCA2 mutations in Scotland and Northern Ireland

Publicado 2003

Weekly high-dose cisplatin is a feasible treatment option: analysis on prognostic factors for toxicity in 400 patients

por de Jongh, F E, van Veen, R N, Veltman, S J, de Wit, R, van der Burg, M E L, van den Bent, M J, Planting, ASTh, Graveland, W J, Stoter, G, Verweij, J
Publicado 2003

Reporting of prognostic markers: current problems and development of guidelines for evidence-based practice in the future

por Riley, R D, Abrams, K R, Sutton, A J, Lambert, P C, Jones, D R, Heney, D, Burchill, S A
Publicado 2003

Pepsinogen A, pepsinogen C, and gastrin as markers of atrophic chronic gastritis in European dyspeptics

por Broutet, N, Plebani, M, Sakarovitch, C, Sipponen, P, Mégraud, F
Publicado 2003

Sustained antiproliferative mechanisms by RB24, a targeted precursor of multiple inhibitors of epidermal growth factor receptor and a DNA alkylating agent in the A431 epidermal car...

por Banerjee, R, Rachid, Z, Qiu, Q, McNamee, J P, Tari, A M, Jean-Claude, B J
Publicado 2004

Microenvironmental adaptation of experimental tumours to chronic vs acute hypoxia

por Thews, O, Wolloscheck, T, Dillenburg, W, Kraus, S, Kelleher, D K, Konerding, M A, Vaupel, P
Publicado 2004

Recombinant humanised anti-HER2/neu antibody (Herceptin®) induces cellular death of glioblastomas

por Mineo, J-F, Bordron, A, Quintin-Roué, I, Loisel, S, Ster, K L, Buhé, V, Lagarde, N, Berthou, C
Publicado 2004

Phase II trial of carboplatin and etoposide for patients with recurrent high-grade glioma

por Franceschi, E, Cavallo, G, Scopece, L, Paioli, A, Pession, A, Magrini, E, Conforti, R, Palmerini, E, Bartolini, S, Rimondini, S, Esposti, R Degli, Crinò, L
Publicado 2004

No topoisomerase I alteration in a neuroblastoma model with in vivo acquired resistance to irinotecan

por Calvet, L, Santos, A, Valent, A, Terrier-Lacombe, M-J, Opolon, P, Merlin, J-L, Aubert, G, Morizet, J, Schellens, J H M, Bénard, J, Vassal, G
Publicado 2004

Abrogation of IL-6-mediated JAK signalling by the cyclopentenone prostaglandin 15d-PGJ(2) in oral squamous carcinoma cells

por Siavash, H, Nikitakis, N G, Sauk, J J
Publicado 2004

A novel 1p36.2 located gene, APITD1, with tumour-suppressive properties and a putative p53-binding domain, shows low expression in neuroblastoma tumours

por Krona, C, Ejeskär, K, Carén, H, Abel, F, Sjöberg, R-M, Martinsson, T
Publicado 2004

Frequent downregulation of 14-3-3 σ protein and hypermethylation of 14-3-3 σ gene in salivary gland adenoid cystic carcinoma

por Uchida, D, Begum, N-M, Almofti, A, Kawamata, H, Yoshida, H, Sato, M
Publicado 2004

Long-term outcome of radiological-guided insertion of implanted central venous access port devices (CVAPD) for the delivery of chemotherapy in cancer patients: institutional experi...

por Vardy, J, Engelhardt, K, Cox, K, Jacquet, J, McDade, A, Boyer, M, Beale, P, Stockler, M, Loneragan, R, Dennien, B, Waugh, R, Clarke, S J
Publicado 2004

Fulvestrant is an effective and well-tolerated endocrine therapy for postmenopausal women with advanced breast cancer: results from clinical trials

por Vergote, I, Robertson, J F R
Publicado 2004

Pre-operative urinary cathepsin D is associated with survival in patients with renal cell carcinoma

por Vasudev, N S, Sim, S, Cairns, D A, Ferguson, R E, Craven, R A, Stanley, A, Cartledge, J, Thompson, D, Selby, P J, Banks, R E
Publicado 2009

Surgery with curative-intent in patients treated with first-line chemotherapy plus bevacizumab for metastatic colorectal cancer First BEAT and the randomised phase-III NO16966 tria...

por Okines, A, Puerto, O del, Cunningham, D, Chau, I, Van Cutsem, E, Saltz, L, Cassidy, J
Publicado 2009

Hsp-27 expression at diagnosis predicts poor clinical outcome in prostate cancer independent of ETS-gene rearrangement

por Foster, C S, Dodson, A R, Ambroisine, L, Fisher, G, Møller, H, Clark, J, Attard, G, De-Bono, J, Scardino, P, Reuter, V E, Cooper, C S, Berney, D M, Cuzick, J
Publicado 2009

VEGF(121)b, a new member of the VEGF(xxx)b family of VEGF-A splice isoforms, inhibits neovascularisation and tumour growth in vivo

por Rennel, E S, Varey, A H R, Churchill, A J, Wheatley, E R, Stewart, L, Mather, S, Bates, D O, Harper, S J
Publicado 2009

Serum triglyceride concentrations and cancer risk in a large cohort study in Austria

por Ulmer, H, Borena, W, Rapp, K, Klenk, J, Strasak, A, Diem, G, Concin, H, Nagel, G
Publicado 2009